Dopamine receptor mRNAs in the rat lymphocytes

Life Sciences

Volumn 62, Issue 21, 1998, Pages 1919-1925

  Caronti, Brunella ^a   Calderaro, Caterina ^a   Passarelli, Francesca ^a   Palladini, Guido ^a   Pontieri, Francesco E ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dopamine receptor; Lymphocytes; MRNA

Indexed keywords

DOPAMINE RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CORPUS STRIATUM; DRUG RECEPTOR BINDING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MEMBRANE; MOLECULAR INTERACTION; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CORPUS STRIATUM; LYMPHOCYTES; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE;

ANIMALIA;

EID: 0032540180     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00160-X     Document Type: Article

References (24)

1. 1. R. ADER, D. FELTEN and N. COHEN. Annu. Rev. Pharmacol. Toxicol. 30 561-602 (1990).
2. 2. D.N. KHANSARI, A.J. MURGO and R.E. FAITH. Immunol. Today 11 170-175 (1990).
3. 3. E. NAGY, I. BERCZI, G.E. WREN, S.L. ASA and K. KOWACS. Immunopharmacology 6 231-243 (1983).
4. 4. J.M. CHAPDELAINE, T.C. WARREN, J.D. WAALEN, P.M. GROB and P.H. WOOLEY. Arth. Rheum. 31 (suppl.) S89-S93 (1988).
5. 5. J.C. SCHWARTZ, B. GIROS, M.P. MARTRES, and P. SOKOLOFF. Sem. Neurosci. 4 99-108 (1992).
6. 6. P. SOKOLOFF and J.C. SCHWARTZ. Trends Pharmacol. Sci. 16 270-275 (1995).
7. 7. Y. NAGAI, S. UENO, Y. SAEKI, F. SOGA and T. YANAGIHARA. Biochem. Biophys. Res. Com. 194 368-374 (1993).
8. 8. N. TAKAHASHI, Y. NAGAI, S. UENO, Y. SAEKI, and T. YANAGIHARA. FEBS Lett. 314 23-25 (1992).
9. 9. A. RICCI and F. AMENTA. J. Neuroimmunol. 53 1-7 (1994).
10. 10. A. RICCI, J.A. VEGA and F. AMENTA. J. Neuroimmunol. 50 133-138 (1994).
11. 11. F. J. Jr. MONSMA, L.C. MAHAN, L.D. McVITTIE, C.R. GERFEN and D.R. SIBLEY. Proc .Natl. Acad. Sci. USA 87 6723-6727 (1990).
12. 12. D.D. RAO , J. McKELVY, J. KEBABIAN and R.G. MacKENZIE. FEBS Lett. 263 18-22 (1990).
13. 13. P. SOKOLOFF, B. GIROS, M.P. MARTRES, M.L. BOUTHENET and J.C. SCHWARTZ. Nature 347 146-151 (1990).
14. 14. K.L. O'MALLEY, S. HARMON, L. TANG and R.D. TODD. New Biol. 4 137-146 (1992).
15. 15. M. TIBERI, K.R. JARVIE, C. SILVIA, P. FALARDEAU, J.A.. GINGRICH, N. GODINOT, L. BERTRAND, T.L. YANG-FENG, R.T. Jr FREMEAU and M.G. CARON. Proc. Natl. Acad. Sci. USA 88 7491-7495 (1991).
16. 16. P. PONTE, S.Y. NG, Y. ENGEL, P. GUNNING and L. KEDES. Nucleic Acids Res 12 1687-1696 (1984).
17. 17. S.Y. NG, P. GUNNING, R. EDDY, P. PONTE, J. LEAVIT, T. SHOWS and L. KEDES. Mol Cell Biol 5 2720-2732 (1985).
18. 18. B.J. CLARK. Peripheral Dopamine Pathophysiology. F. AMENTA (Ed.) 253-255. CRC Press,. Boca Raton (1990).
19. 19. J. BERGQUIST, A. TARKOWSKI, R. EKMAN and A. EWING. Proc. Natl. Acad. Sci. USA 91 12912-12916 (1994).
20. 20. M. MATSUMOTO, K. HIDAKA, S. TADA, Y. TASAKI and T. YAMAGUCHI. J. Neurochem. 66 915-919 (1993).
21. 21. M.J. HURLEY, C.M. STUBBS, P. JENNER and C.D. MARSDEN. Psychopharmacology 128 362-370 (1996).
22. 22. M.L. FIGLIOMENI and R.M. TURKELL. Immunopharmacology 36 41-48 (1997).
23. 23. A.A. BOHN, C.S. FORSYTH, N.I. KERVLIET and A.A. FRANK. Toxicol. Lett. 91 47-55 (1997).
24. 24. Y. NAGAI, S. UENO, Y. SAEKI, F. SOGA, M. HIRANO and T. YANAGIHARA. Neurology 46 791-795 (1996).